Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. (Nasdaq: ATEC) is a spine-focused medical device company whose news flow centers on spine surgery innovation, financial performance, and strategic collaborations. Through subsidiaries such as Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc., ATEC regularly issues updates on procedural technologies, imaging platforms, and neuro-monitoring systems that support its goal of revolutionizing spine surgery.
Investors and clinicians following ATEC news can expect frequent announcements of quarterly and annual financial results, including commentary on surgical revenue, EOS revenue, adjusted EBITDA, and free cash flow. The company often pairs its earnings releases with updated full-year outlooks, highlighting trends in surgical volume growth, new surgeon adoption, and the performance of its procedural ecosystems such as PTP™ and LTP™.
ATEC’s news stream also features product and platform launches, such as the commercial introduction of the PTP™ Corpectomy system, which expands its Prone TransPsoas approach to complex thoracolumbar pathologies. These announcements provide detail on systems like the Sigma™ LIF Corpectomy Access System, Ascend™ NanoTec™ Vertebral Body Replacement System, and SafeOp™ Neural InformatiX™ System, illustrating how the company integrates access, implants, and neuro-monitoring into a unified procedural offering.
Strategic and corporate developments are another recurring theme. Recent news includes a definitive partnership with Theradaptive, Inc. granting ATEC exclusive U.S. commercial rights to OsteoAdapt®, an osteoinductive bone graft for spinal fusion built on AMP2™ protein technology. The company also issues releases about participation in major healthcare and medtech conferences, board-related updates, and inducement equity awards for new employees. This news page aggregates these items so readers can track how ATEC’s spine-only strategy, innovation pipeline, and financial trajectory evolve over time.
Alphatec Holdings (Nasdaq: ATEC) will showcase its informatics-integrated spine procedures at the North American Spine Society (NASS) 29th Annual Meeting from September 25-27, 2024, in Chicago. The company will highlight its approach-specific technologies coupled with proprietary informatics like EOS Insight and SafeOp to improve spine surgery outcomes. Key presentations include a demonstration of ATEC's Prone TransPsoas (PTP) Approach and discussions on lateral surgery evolution and EOS Insight's impact on deformity surgery durability.
Additionally, ATEC granted 38,374 restricted stock units (RSUs) to 14 new employees as employment inducements, vesting over four years or fully upon a change of control.
Alphatec Holdings (NASDAQ:ATEC) reported strong Q2 2024 financial results, with total revenue growing 25% to $146 million. Surgical revenue increased by 27%, driving overall growth. The company has raised its full-year guidance, now expecting total revenue to grow 25% to $602 million and non-GAAP adjusted EBITDA of approximately $25.5 million.
Key highlights include the launch of EOS Insight™, expansion in major markets, 20% growth in new surgeon adoption, and the appointment of Keith Valentine to the Board of Directors. ATEC achieved profitability milestones and continues to focus on self-funded growth. The company's strategic initiatives and spine-focused approach are yielding positive results, positioning ATEC for continued success in the spine surgery market.
Alphatec Holdings (ATEC), a spine surgery solutions provider, announced its participation in four upcoming investor conferences:
- RBC West Coast Medical Device Bus Tour on August 14, 2024
- Piper Sandler MedTech and Diagnostics California Bus Tour on August 21, 2024
- Morgan Stanley Global Healthcare Conference on September 4, 2024
- Wells Fargo Healthcare Conference on September 5, 2024
Live webcasts, if available, will be accessible on ATEC's Investor Relations website. Additionally, ATEC granted 44,772 restricted stock units (RSUs) to 22 new non-executive employees as employment inducement. These RSUs will vest over four years and fully upon a change of control.
ATEC (Nasdaq: ATEC) has launched EOS Insight, an innovative end-to-end spine surgery platform powered by EOSedge scans and AI. The first EOS Insight-informed surgeries were successfully performed at OrthoIndy Hospital. This groundbreaking platform leverages AI to provide important information throughout multiple stages of spine care, including:
- AI-driven alignment calculation
- 3D-surgical planning simulations
- Patient-specific rods
- Intra-operative reconciliation
- Post-operative analytics
EOS Insight aims to modernize spine surgery by replacing archaic clinical practices and improving patient outcomes. The platform's ability to automate processes and integrate alignment data into surgical plans positions ATEC as a potential standard-bearer in spine care.
Alphatec Holdings (Nasdaq: ATEC) announced it will report its Q2 2024 financial results on July 31, 2024, after the market close. A live webcast will be hosted at 1:30 p.m. PT / 4:30 p.m. ET, accessible through the Investor Relations section of the company's website. Participants can dial into the webcast after registering online, and a replay will be available for twelve months.
In related news, ATEC's independent Compensation Committee approved inducement grants for 30 new employees, totaling 47,112 restricted stock units (RSUs). These RSUs will vest annually over four years, contingent on continuous employment, and will fully vest upon a change of control of the company.
Alphatec Holdings, Inc. (Nasdaq: ATEC) reported a 27% growth in total revenue to $138 million, with 30% increase in surgical revenue. Adjusted EBITDA margin expanded by 450 basis points. Full-year revenue and adjusted EBITDA guidance raised to $601 million and $23 million respectively. The company experienced growth in surgical revenue, surgeon adoption, and U.S. footprint expansion. Ending cash balance was $144 million. Non-GAAP gross margin was 71%. The CEO expressed confidence in the company's future growth potential.
Alphatec Holdings, Inc. (Nasdaq: ATEC) will be participating in several investor conferences in May and June 2024. The company also granted 14,024 restricted stock units to new employees as an inducement to accepting employment, which will vest in equal annual installments on each of the first four anniversaries of the grant date, contingent on the recipient's continuous employment with ATEC.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Alphatec Hldgs (ATEC)?
What is the market cap of Alphatec Hldgs (ATEC)?
